AMERICAN HEART ASSOCIATION
The American Heart Association – building healthier lives, free of cardiovascular diseases and stroke. Visit our booth during EAS to learn more about the AHA, its programs, and our journals, including Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB). ATVB is the top journal in its field and publishes some of the best articles focused on basic, translational, clinical, and population research. For more information, please visit https://my.americanheart.org or https://atvb.ahajournals.org. You can also "Like" our Facebook page (ATVB), follow us on Twitter (@atvbahajournals), or find us on LinkedIn (https://www.linkedin.com/pub/atvb-journal/61/a18/366).
Lake Geneva Business Park
Route de Crassier, 7
Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. Our lead product, lomitapide (branded as Lojuxta® in the EU) is authorised as an adjunct to a low-fat diet and other lipid-lowering medicinal products with or without low density lipoprotein (LDL) apheresis in adult patients with homozygous familial hypercholesterolaemia (HoFH). HoFH is caused by genetic defects inherited from both parents that affect the function of the LDL receptor, responsible for removing LDL-C cholesterol from the body. HoFH is characterized by extremely high levels of LDL cholesterol and premature, severe and progressive atherosclerosis.
Amgen (Europe) GmbH.
Dammstrasse 23, CH-6301 Zug
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realise the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed medical practice, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to improve people's lives dramatically. To learn more about our pioneering science and vital medicines, visit www.amgen.com.
SE-431 83 Mölndal
AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.
BASFCarl-Bosch-Strasse 38Ludwigshafen,Rhineland-Palatinate Germanywebsite: https://www.basf.cm www.newtrition.com
BASF's Nutrition & Health division develops, produces and markets a comprehensive range of products and services for the human and animal nutrition, pharmaceutical as well as flavor and fragrance industries. The division strives to contribute to a better life through improving the nutrition, health and wellbeing of people across the world. Important human nutrition products are vitamins and carotenoids, plant sterols, emulsifiers and omega-3 fatty acids. Its feed additives such as vitamins, carotenoids, enzymes and organic acids make Nutrition &Health a worldwide leader for the animal nutrition market. The division provides the pharmaceutical industry with active ingredients such as caffeine and ibuprofen, as well as excipients and custom synthesis services. Furthermore, it produces aroma ingredients such as citral, geraniol and L-menthol for the flavor and fragrance industry.
Chiesi Farmaceutici is a research-focused international group, with more than 75 years of experience headquartered in Parma (Italy). Chiesi researches, develops and commercializes innovative pharmaceutical solutions in the respiratory therapeutics, specialist medicine and rare disease areas.
For more information, please visit www.chiesi.com
17 Boulevard Haussmann
75009 Paris cedex
Danone is an international company present on five continents. The group holds top positions in healthy food through four businesses: Fresh Dairy Products, Waters, Baby Nutrition and Medical Nutrition. Its mission is to bring health through food to as many people as possible. Danone has more than 190 production plants and around 102,000 employees. In 2012, the company generated sales of over €20 billion, with more than 50% in emerging countries.
Listed on NYSE Euronext Paris, Danone is a component stock of leading social responsibility indexes including the Dow Jones Sustainability Indexes, ASPI Eurozone, the Ethibel Sustainability Index and the ATNI index.
DENKA SEIKEN CO., LTD
Nihonbashi Mitsui Tower,
Chuo-ku, Tokyo 103-8338,
Denka Seiken manufactures clinical chemistry and latex-enhanced serum protein reagents for automated chemistry analyzers such as CRP, Lp(a), HDL-C, LDL-C, etc. Denka Seiken currently features a reagent that can quantitatively determine small, dense low-density lipoproteins (small, dense LDL). The s LDL-EX "SEIKEN" is a homogeneous assay consisting of two ready-to-use liquid reagents to be used on automated chemistry analyzers. The test is fully automated and has within-run precisions of 1 – 2 %. Test result is available in 10 minutes, and the assay methodology correlates well with the traditional ultracentrifugation method.
Denka Seiken is now also offering new homogeneous assays to quantify HDL subfractions (HDL3 and ApoE-containing HDL-C), Remnant Lipoproteins, LDL-TG and Adiponectin in serum/plasma. They are also fully automated and can be used on automated chemistry analyzers.
349 Oyster Point Blvd.
South San Francisco, CA 94080
diaDexus, Inc., based in South San Francisco, California, develops and commercializes proprietary cardiovascular diagnostic products addressing unmet needs in cardiovascular disease. The diaDexus PLAC® Test identifies active cardiovascular inflammatory disease and aids in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. The PLAC Test is a simple blood test that measures Lp-PLA2, a vascular-specific inflammatory marker critical in the formation of rupture-prone plaque. Most cardiovascular events are due to plaque rupture; the higher the level of Lp-PLA2, the higher the risk for a cardiovascular event, For more information please visit the company's website at www.plactest.com.
EUROPEAN ATHEROSCLEROSIS SOCIETY
Kronhusgatan 11, 411 05
The Society's aim is to provide a framework for scientific and clinical discussion of new developments in basic research, diagnosis and therapy of atherosclerosis, through publication of Guidelines and Consensus Position Papers, and its official journal Atherosclerosis, and through educational activities, including annual Congress, Advanced Courses and online through the EAS Academy.
FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
Bad Homburg v.d.H., 61352
Therapeutic Apheresis is a division of Fresenius Medical Care, the world's largest fully integrated renal healthcare company. Therapeutic Apheresis is used to treat therapy refractory patients. Harmful pathogenic antibodies produced by the patient's own body occur in many clinical settings such as various autoimmune diseases or as responses to transplanted organs. Immunosorba and GLOBAFFIN are mainly used for the treatment of autoimmune diseases and antibody mediated transplant rejections (e.g. DCM, Pemphigus, MG, GBS, SLE, AHR). In patients suffering from severe hypercholesterolaemia the only effective therapy option to reduce LDL cholesterol and to improve the prognosis is LDL apheresis with DALI or MONET.
ITAMAR MEDICAL LTD
9 halamish Street
Caesarea Ind. Park 3088900
Itamar Medical's EndoPAT™ device, clinically validated by leading cardiologists to accurately assess endothelial function, is the only FDA-cleared test out in the market today, for non-invasive assessment of Endothelial function. The EndoPAT™ test is reimbursable, simple, takes only 15 minutes and can be easily performed by a medical assistant at the clinic.
The EndoPAT™ test is now backed by unparalleled body of hundreds of scientific peer-reviewed papers, demonstrating the role of endothelial function as a key marker of sub-clinical atherosclerosis and a predictor of cardiovascular events beyond commonly used tests.
KOWA PHARMACEUTICAL EUROPE CO. LTD.
105 Wharfedale Road
Wokingham RG41 5RB
Kowa Pharmaceutical Europe Co. Ltd. is a specialty pharmaceutical company established in 2000 and located in the UK, which focuses primarily on cardiometabolic therapeutics including pitavastatin.
Kowa is committed to ground-breaking drug research, development and marketing and seeks to ensure quality products are made available to people within Europe and beyond, looking to contribute to a better standard of health and a more comfortable life for all.
131 28 Nacka Strand
Mabtech is a Swedish Biotech company that produces high quality monoclonal antibodies for ELISA, ELISpot, WB and IP. We offer reagents and kits for sensitive and specific detection of apolipoproteins, cytokines and immunoglobulins. We have for many years been a world leader in ELISpot and with a strong research focus we continuously optimize our techniques and services. Our customers appreciate our high quality reagents, fast delivery, technical support and scientific knowledge.
At EAS-2014 we will present our latest intriguing results about apoD. By working together, we can achieve results that influence research development. Meet us at booth 14.
Mercodia ABis a Swedish biotech company focusing on the development of immunoassays for research within the field of metabolic disorders. Our assays are applicable to bothanimal and human models and are used for research ranging frombasic scientific studies to large pre-clinical and clinical phase trials.
The company was foundedin1991 and is today a world-leadingsupplier ofproducts to all major international markets. More than ninety percent of our production is exported from ourfacilities in Uppsala to approximately 100 different countriesaround the world.
Mercodia provides a professional scientific support system by collaborating with customers and institutions worldwide to develop novelapplications for existing products and unique diagnostics for emerging market.
Merck & Co., PO Box 1000, Upper Gwynedd
Today's MSD is a global healthcare leader working to help the world be well. MSD is known as Merck in the United States and Canada. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships.
P.O. Box 101,
Benecol® - proven to reduce cholesterol
Raisio Group is an expert in plant-based nutrition with strong international and local food brands. Benecol® is the expert brand in cholesterol reduction and a pioneer in the cholesterol lowering functional food category.
Raisio Group produces the unique cholesterol-lowering ingredient, Plant stanol ester, and licenses the Benecol brand worldwide. Benecol products are manufactured and sold by local food companies in 30 countries on five continents.
Over 70 clinical studies support the use of Benecol as an effective, easy and safe dietary tool to lower LDL-cholesterol. The cholesterol-lowering effect of Benecol is additive to those of a healthy diet and statin medication.
Via Valosa di Sopra 9
Rottapharm|Madaus has established a worldwide expertise in several medical fields.
The dietary supplements developed fall into the same therapeutic categories in which the Group has a wealth of experience.
The cardiovascular area of nutraceuticals is represented by Armolipid product line (patented), dietary supplements with natural substances for the control of blood lipids when integrated in an adequate diet for such purposes.
The ingredients of Armolipid product line derive from high quality natural extracts with very well documented activity.
The production process follows pharmaceutical quality standards, every product is clinically tested and the results of clinical trials published in peer-reviewed international medical journals.
Sanofi, a global healthcare leader, discovers, develops, and distributes therapeutic solutions focused on patients' needs. Regeneron, a leading biopharmaceutical company, discovers, develops, manufactures, and commercializes biologic medicines for serious medical conditions. Since 2007, Sanofi and Regeneron have collaborated to develop and commercialize fully human monoclonal antibodies utilizing proprietary technologies.
SPANISH SOCIETY OF ATHEROSCLEROSIS
The Society groups professionals in Medicine, Surgery, Health Sciences and other relevant fields concerned with Atherosclerosis in all its aspects: epidemiology, prevention, etiopathogeny, physiopathology, clinical manifestations, diagnosis, medical or surgical treatment, or rehabilitation, united in their ambition to promote investigation, education and quality assistance in the field. An academic association with a clear reference point as regards vascular risk factors with a both national and international profile, widely present in the international scientific environment, the health care and social sectors. The society remains with a clear compromiso with scientific knowledge, patients and improvements in health care results.
SYNAGEVA BIOPHARMA CORP.
33 Hayden Ave.
Lexington, MA 02421
Synageva BioPharma Corp. is a biopharmaceutical company working to deliver breakthrough medicines globally for patients suffering from rare, devastating diseases. Our lead program, sebelipase alfa (SBC-102), is a recombinant human enzyme replacement therapy for Lysosomal Acid Lipase Deficiency (LAL D). LAL D is a rare systemic disease characterized by decreased LAL enzyme activity with intracellular accumulation of lipids. This disease leads to medical complications with significant morbidity and early mortality. For more information on LAL D, please contact email@example.com.
Unilever Research & Development Vlaardingen, Netherlands
Olivier van Noortlaan 120
Make sustainable living commonplace
Unilever's purpose is to make sustainable living commonplace. We help people feel good, look good and get more out of life with brands and services that are good for them and good for others. 160 million times a day, in 190 countries, people use our home, personal care and foods products at key moments of their day. We produce world-leading brands including Lipton, Knorr, Hellmann's Becel/Flora, Ben & Jerry's, Dove, Axe, and Omo.
WISEPRESS MEDICAL BOOKSHOP
25 High Path, Merton Abbey
London, SW19 2JL, UK
Wisepress.com, Europe's leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.